Diagnostics


  • A view of Building 1 at Cepheid headquarters in Sunnyvale, California. Cepheid plans to consolidate manufacturing activities at its Sunnyvale headquarters.
    Image attribution tooltip
    The image by Coolcaesar is licensed under CC BY-SA 4.0
    Image attribution tooltip

    Danaher’s Cepheid business to lay off 67 people in California

    The job cuts at Danaher’s molecular diagnostics subsidiary will take place by the end of the year and affect mostly scientists and engineers, according to a state filing.

    By • Nov. 11, 2026
  • A robotic surgery system is displayed.
    Image attribution tooltip
    Courtesy of Virtuoso Surgical
    Image attribution tooltip

    Virtuoso robot wins FDA nod for bladder tumor removal

    Virtuoso Surgical’s robotic system can remove lesions in one piece in a minimally invasive procedure designed to improve cancer diagnosis and staging.

    By • Nov. 10, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Explore the Trendline➔
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • A picture of the exterior of a Labcorp building.
    Image attribution tooltip
    Courtesy of Labcorp
    Image attribution tooltip

    Labcorp completes $375M Millennium Health takeover

    The deal, which includes a $245 million upfront fee, expands the geographic reach of Labcorp’s drug testing business.

    By • Nov. 9, 2026
  • A headshot of Solomon Moshkevich
    Image attribution tooltip
    Permission granted by Natera
    Image attribution tooltip

    Natera promotes Solomon Moshkevich to CEO

    The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for the role.

    By • Nov. 6, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers to rebrand and separate its IVD business

    The company is rebranding the unit as Olyrian Diagnostics and plans to set it up as a standalone business by mid-2028.

    By • Nov. 6, 2026
  • MRI machine
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Bracco invests $230M to build US plant for injectable contrast media

    The Sanford, North Carolina, facility will become the company’s first manufacturing site for injectable contrast media in the U.S.

    By • Nov. 3, 2026
  • The facade of the U.S. Capitol building is seen along with trees and a reflection pond
    Image attribution tooltip
    Kara Arundel/MedTech Dive
    Image attribution tooltip

    Labcorp, Quest urge RESULTS Act passage as lab payment cuts loom

    The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross the finish line in Congress’ lame-duck session.

    By • Oct. 30, 2026
  • A portrait of Rick Baehner
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott launches MRD test with improved cancer detection tech

    Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

    By • Oct. 27, 2026
  • A Labcorp sign in front of an office building and palm trees.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Labcorp inks Millennium Health buyout to add drug testing services

    The proposed acquisition of the specialty laboratory is the third Labcorp buyout announced in eight days.

    By • Oct. 26, 2026
  • A person wearing goggles and a mask taps a tablet screen attached to a square machine.
    Image attribution tooltip
    Courtesy of Qiagen
    Image attribution tooltip

    Qiagen agrees to private equity takeover

    EQT Private Equity has agreed to pay about $12.1 billion, including debt, for the diagnostics company, which has long been the subject of takeover speculation.

    By • Oct. 23, 2026
  • A Labcorp sign in front of an office building and palm trees.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Labcorp to buy Myriad’s prenatal health testing unit for $210M

    Buying the Myriad assets will expand Labcorp’s portfolio of specialty tests for women’s health.

    By • Oct. 22, 2026
  • A worker in white coat and purple gloves scans a Galleri test box.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    5 doctors weigh in on the promise, limitations of Grail’s multicancer test

    As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer experts what encourages and concerns them most about Galleri.

    By • Oct. 19, 2026
  • A Labcorp sign in front of an office building and palm trees.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Labcorp to buy BioReference assets for up to $872M

    Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.

    By • Oct. 15, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers to stop selling general ultrasound systems

    In a strategy shift, the company will invest in its procedural ultrasound business, supporting cardiovascular surgeries

    By • Oct. 14, 2026
  • A sign announces the company name at Agilent's headquarters building in Santa Clara, California.
    Image attribution tooltip
    Permission granted by Agilent
    Image attribution tooltip

    Agilent to buy Proscia for $240M

    The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.

    By • Oct. 14, 2026
  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips updates instructions for ultrasound system linked to 4 deaths

    A software issue can delay use of the Lumify diagnostic ultrasound system in environments without access to Wi-Fi or cellular signal.

    By • Oct. 12, 2026
  • A large group of employees stand outside a facility.
    Image attribution tooltip
    Courtesy of BD
    Image attribution tooltip

    BD strikes supply chain pact with Trump administration

    BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.

    By • Oct. 6, 2026
  • A scientist in white jacket operates radiopharmaceutical manufacturing equipment.
    Image attribution tooltip
    Courtesy of GE HealthCare
    Image attribution tooltip

    GE HealthCare to acquire Sofie Biosciences for $945M

    Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.

    By • Oct. 5, 2026
  • A person wearing a white, round patch on their upper arm holds a phone.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    ARPA-H awards more than $100M to biosensor development projects

    Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.

    By • Oct. 5, 2026
  • Doctors looking at MRI imaging on screen
    Image attribution tooltip

    iStock/ gorodenkoff

    Image attribution tooltip
    Sponsored by Veeva MedTech

    Thermo Fisher Scientific accelerates market access by prioritizing the right KOLs

    Thermo Fisher turned fragmented KOL data into real-time market demand. Read how.

    Oct. 5, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA to prioritize guidance on AI, surgical robots next year

    The FDA outlined its A-list and B-list guidance priorities for the 2027 fiscal year.

    By • Oct. 2, 2026
  • A Freenome employee wearing a white coat and purple gloves is shown working in a laboratory.
    Image attribution tooltip
    Permission granted by Freenome
    Image attribution tooltip

    Abbott launches Freenome’s colorectal cancer screening test

    Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.

    By • Sept. 30, 2026
  • A female scientist fills a well plate with a pipette while working in a laboratory.
    Image attribution tooltip
    izusek via Getty Images
    Image attribution tooltip

    Lab test providers want Medicare payment reform. Will Congress pass it?

    Facing maximum Medicare payment cuts, test providers Quest Diagnostics and Labcorp are urging lawmakers to revamp the rate-setting process, but getting a bill through Congress this year will be a challenge.

    By • Sept. 25, 2026
  • A hand in a blue glove holds a blood sample.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    Grail multicancer detection test wins FDA advisers’ backing

    Members of the molecular and clinical genetics panel said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings.

    By • Sept. 24, 2026
  • Test tube blood
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CMS sets preliminary cuts to Medicare lab reimbursement rates

    The American Clinical Laboratory Association warned the steep annual payment cuts threaten patient access to critical lab testing services.

    By • Sept. 22, 2026